Zonisamide
Indication
Migraine prophylaxis
Amber level 0
Brand:
Zonegran®
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Central nervous system
Background
AMBER0 in patients when at least three prior prophylactic treatments have failed and erenumab, galcanezumab or fremanezumab are being considered.
Periodic review by specialist services is necessary to ensure that a patient continues to benefit from treatment with zonisamide.
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist
Supporting documents: